Evidence-based consensus guidelines for the diagnosis and management of protoporphyria-related liver dysfunction in ePP & XLP

Written By Anna Mann

Hepatology 79(3):p 731-743, March 2024. | DOI: 10.1097/HEP.0000000000000546

These consensus guidelines offer a standardized framework for the detection, evaluation, and tailored management of hepatic complications in erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP), aiming to improve patient outcomes through proactive, multidisciplinary care. 

The guidelines were developed through the NIH-funded Porphyrias Consortium.

 

Authors

Levy, Cynthia; Dickey, Amy; Wang, Bruce; Thapar, Manish; Naik, Hetanshi; Keel, Siobán B.; Saberi, Behnam; Beaven, Simon W.; Rudnick, Sean; Elmariah, Sarina; Erwin, Angelika; Goddu, Robert; Hedstrom, Karli; Leaf, Rebecca Karp; Kazamel, Mohamed; Mazepa, Marshall; Philpotts, Lisa Liang; Quigley, John; Raef, Haya; Ungar, Jonathan; Anderson, Karl; Balwani, Manisha; on behalf of the Porphyrias Consortium of the Rare Diseases Clinical Network

Anna Mann
Previous

Update on heme biosynthesis, tissue-specific regulation, heme transport, relation to iron metabolism and cellular energy
Next

Evidence-based consensus guidelines for the diagnosis and management of erythropoietic protoporphyria and X-linked protoporphyria